Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Cancer Gene Therapy
Patricia C RyanPaul L Hallenbeck

Abstract

A potentially promising treatment of metastatic cancer is the systemic delivery of oncolytic adenoviruses. This requires engineering viruses which selectively replicate in tumors. We have constructed such an oncolytic adenovirus, OAS403, in which two early region genes are under the control of tumor-selective promoters that play a role in two key pathways involved in tumorigenesis. The early region E1A is controlled by the promoter for the E2F-1 gene, a transcription factor that primarily upregulates genes for cell growth. The E4 region is under control of the promoter for human telomerase reverse transcriptase, a gene upregulated in most cancer cells. OAS403 was evaluated in vitro on a panel of human cells and found to elicit tumor-selective cell killing. Also, OAS403 was less toxic in human hepatocyte cultures, as well as in vivo when compared to an oncolytic virus that lacked selective E4 control. A single intravenous injection of 3 x 10(12) vp/kg in a Hep3B xenograft mouse tumor model led to significant antitumor efficacy. Additionally, systemic administration in a pre-established LNCaP prostate tumor model resulted in over 80% complete tumor regressions at a tolerable dose. Vector genome copy number was measured in tumors ...Continue Reading

References

Apr 1, 1995·Seminars in Cancer Biology·P D Adams, W G Kaelin
Feb 1, 1993·Journal of Clinical Pathology·H J PorterP J Berry
Nov 1, 1996·Journal of Virology·N MitterederB C Trapnell
Apr 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·T C HeB Vogelstein
Jan 1, 1995·Progress in Cell Cycle Research·J Zwicker, R Müller
Apr 30, 1998·Computers and Biomedical Research, an International Journal·P S Panse Silveira, E Massad
Aug 8, 1998·Genes & Development·N Dyson
Oct 12, 1999·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·W G Kaelin
Jul 11, 2000·Nature Biotechnology·R AlemanyD T Curiel
Sep 6, 2000·The Journal of Biological Chemistry·L YinC Giardina
Sep 14, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·J A BristolS Connelly
Oct 20, 2000·The Journal of General Virology·W C Russell
Feb 13, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·N TaoS E Fawell
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NemunaitisD Kirn
Jul 7, 2001·Human Gene Therapy·J MiA Lieber
Dec 26, 2001·Oncogene·B Täuber, T Dobner
Feb 2, 2002·Nature Reviews. Molecular Cell Biology·Jeffrey M Trimarchi, Jacqueline A Lees
Mar 22, 2002·The Lancet Oncology·Lynda K HawkinsDavid Kirn
May 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Theodore SmithSusan C Stevenson
Jul 15, 2003·Gene Therapy·T-G HuangS L C Woo

❮ Previous
Next ❯

Citations

Dec 24, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kathryn Ottolino-PerryJ Andrea McCart
Oct 19, 2007·Nature Reviews. Cancer·Douglas HedleyCaroline Springer
Jun 21, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Manel CascalloRamon Alemany
Feb 27, 2008·World Journal of Gastroenterology : WJG·Yue-Min LiQi-Jun Qian
Apr 28, 2009·Advanced Drug Delivery Reviews·Dominik E Dorer, Dirk M Nettelbeck
Dec 24, 2010·Molecular Systems Biology·Lior Nissim, Roy H Bar-Ziv
Oct 17, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiroshi FukuharaTomoki Todo
Jun 27, 2006·Oncogene·M A AvilaJ Prieto
Mar 12, 2004·Oncogene·Candelaria Gomez-ManzanoJuan Fueyo
Sep 13, 2017·Frontiers in Cell and Developmental Biology·Angela Re
Sep 7, 2007·Cancer Research·Marta M AlonsoJuan Fueyo
Dec 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuanhao LiDe-Chao Yu
Sep 18, 2021·Cancer Investigation·Naila MalkaniMuhammad Usman Rashid

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.